1. Clinical utility of dipeptidyl peptidase-4 inhibitors: a descriptive summary of current efficacy trials

   • George Grunberger

   Review Article 02 September 2014 Pages: 1277 - 1289

   

2. Biological agents in management of osteoporosis

   • Sri Harsha Tella
   • J. Christopher Gallagher

   Review Article 11 September 2014 Pages: 1291 - 1301

   

3. Identification of black market products and potential doping agents in Germany 2010–2013

   • Oliver Krug
   • Andreas Thomas
   • Mario Thevis

   Review Article 30 August 2014 Pages: 1303 - 1311

   

4. Breastfeeding and migraine drugs

   • Riccardo Davanzo
   • Jenny Bua
   • Giulia Facchina

   Review Article 13 September 2014 Pages: 1313 - 1324

5. Should nurses or clinical pharmacists perform medication reconciliation? A randomized controlled trial

   • Trine Aag
   • Beate Hennie Garcia
   • Kirsten K. Viktil

   Clinical Trial 04 September 2014 Pages: 1325 - 1332

   

6. Effect of two-linked mutations of the FMO3 gene on itopride metabolism in Chinese healthy volunteers

   • Li-Ping Zhou
   • Zhi-Rong Tan
   • Guo-Gang Zhang

   Pharmacogenetics 17 September 2014 Pages: 1333 - 1338

   

7. Edoxaban population pharmacokinetics and exposure–response analysis in patients with non-valvular atrial fibrillation

   • Ophelia Q. P. Yin
   • Kimura Tetsuya
   • Raymond Miller

   Pharmacokinetics and Disposition 29 August 2014 Pages: 1339 - 1351

   

8. Design and prospective validation of a dosing instrument for continuous infusion of vancomycin: a within-population approach

   • Erik M. van Maarseveen
   • Annemien Bouma
   • Arthur R. H. van Zanten

   Pharmacokinetics and Disposition 30 August 2014 Pages: 1353 - 1359

   

9. Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database

   • Caroline Soussan
   • Aurore Gouraud
   • Isabelle Lacroix

   Pharmacoepidemiology and Prescription 04 September 2014 Pages: 1361 - 1366

   

10. Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study

    • Brit Solvor Riska
    • Svetlana Skurtveit
    • Marte Handal

    Pharmacoepidemiology and Prescription 11 September 2014 Pages: 1367 - 1374

11. A limited number of prescribed drugs account for the great majority of drug-drug interactions

    • Johan Holm
    • Birgit Eiermann
    • Buster Mannheimer

    Pharmacoepidemiology and Prescription 06 September 2014 Pages: 1375 - 1383

12. Outcomes of off-label drug uses in hospitals: a multicentric prospective study

    • I. Danés
    • A. Agustí
    • X. Bonafont

    Pharmacoepidemiology and Prescription Open access 09 September 2014 Pages: 1385 - 1393

    

13. Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study

    • Linda Amundstuen Reppe
    • Olav Spigset
    • Jan Schjøtt

    Pharmacoepidemiology and Prescription Open access 12 September 2014 Pages: 1395 - 1401

    

14. Between-subject variability: should high be the new normal?

    • Hesham S. Al-Sallami
    • Song Lim Cheah
    • Stephen B. Duffull

    Letter to the Editors 05 September 2014 Pages: 1403 - 1404